NCT00701545View on ClinicalTrials.gov

A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced)

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

February 29, 2008

Study Completion Date

April 30, 2009

Conditions
Von Willebrand Disease
Trial Locations (1)

Unknown

Toronto

Sponsors

Lead Sponsor

CSL Behring
All Listed Sponsors
lead

CSL Behring

INDUSTRY